TELIX PHARMACEUTICALS LIMITED.
Australian public company
- Reports this week
- 2
- Active events
- 1
- Connections
- 48
What's happening
Active this week
Earlier this month
-
Merger aims to create a vertically integrated radiopharmaceutical leader.Some support3 reports
-
Telix Pharmaceuticals Limited announced that it is utilizing the Nasdaq exchange for its ADR listing.Some support2 reports
-
TELIX Pharmaceuticals is conducting Phase 3 trials and seeking alignment on the New Drug Application pathway with the FDA.Some support11 reports
One to three months ago
-
Telix Pharmaceuticals Limited, headquartered in Melbourne, has international operations including in Europe and is listed on the Australian Securities Exchange.Well supported12 reports
-
Telix Pharmaceuticals Limited and Regeneron announced a collaboration on May 1, 2026, to jointly develop next-generation radiopharmaceuticals.Some support2 reports
Gone quiet
No new reports in 90+ days-
A company is developing Gozzellix, a next-generation PSMA-PET imaging agent, for prostate cancer treatment, benefiting from Trump-era tariffs and AI stocks.Some support2 reports1 development inside
-
Strategic research partnership established in the US between TELIX PHARMACEUTICALS LIMITED and United Imaging Healthcare.Some support1 report
-
Telix Pharmaceuticals Limited is headquartered in Melbourne, Australia, and an executive is attending a conference in Chicago.Well supported4 reports1 development inside
-
Telix Pharmaceuticals Limited is involved in activities related to Europe.Speculative1 report
-
Telix Pharmaceuticals acquired RLS and received FDA approval for a label expansion of its drug Illuccix.Speculative2 reports
No events began in the chosen period. Widen it, or reset.
Around TELIX PHARMACEUTICALS LIMITED this week
News at the entities that move TELIX PHARMACEUTICALS LIMITED most-
Australian Securities Exchange StructuralThe Australian Securities & Investments Commission implements enhanced disclosure obligations on market activities.Moves TELIX PHARMACEUTICALS LIMITED
-
Nasdaq StructuralApple Inc. stock is traded on Nasdaq, and Jefferies Financial Group restated a hold rating on the company.Moves TELIX PHARMACEUTICALS LIMITED
-
MarketBeat Mentioned togetherMarketBeat aggregates data on IDT Corporation stock performance.Moves TELIX PHARMACEUTICALS LIMITED
-
FDA StructuralGeneric medicine services are seeking approval for launch from the FDA.Moves TELIX PHARMACEUTICALS LIMITED
-
Citigroup TransactionalCitigroup provided analyst ratings and targets for Autodesk stock, which trades on Nasdaq.Moves TELIX PHARMACEUTICALS LIMITED
-
Food and Drug Administration StructuralIn 2007, CBS broadcast featured Andrews, Cordes, and Couric criticizing the Food and Drug Administration's problems.Moves TELIX PHARMACEUTICALS LIMITED
Connections
The 17 strongest of 48, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Australian Securities Exchange Structural
Telix is a company formally listed on the Australian Securities Exchange.
-
FDA Structural
Telix Pharmaceuticals relies on the FDA for regulatory approvals, label expansions, and pathway alignment of its pharmaceutical products.
-
Nasdaq Structural
Telix Pharmaceuticals Limited is formally listed on the Nasdaq stock exchange.
-
PR Newswire Structural
Telix utilizes PR Newswire's service for the distribution of company press releases.
-
Citigroup Transactional
Citigroup reiterated a buy rating on the shares of Telix Pharmaceuticals Limited.
-
Lazard Asset Management LLC Transactional
Lazard Asset Management LLC increased its institutional stake in Telix Pharmaceuticals Limited.
-
Novartis Operational
Telix Pharmaceuticals competes directly with Novartis by developing drugs targeting the same indications as Novartis's Lutathera and Pluvicto.
-
Food and Drug Administration Structural
The FDA's regulatory alignment is shown to advance TELIX PHARMACEUTICALS LIMITED's clinical trials.
Show all 17 connections
-
MarketBeat Mentioned together
MarketBeat, a financial data aggregator, provides coverage and stock ratings for Telix Pharmaceuticals.
-
Belgium Shared context
Telix operates internationally within the geographical context of Belgium.
-
Switzerland Shared context
Telix Pharmaceuticals Limited has international operations within Switzerland.
-
Europe Shared context
Telix Pharmaceuticals Limited conducts international operations within Europe.
-
Sydney Shared context
The company's stock performance is benchmarked against the conditions and market context of Sydney.
-
Melbourne Shared context
Telix Pharmaceuticals Limited is headquartered and conducts operations within Melbourne.
-
New York City Shared context
Telix Pharmaceuticals utilizes New York City as the location for its corporate events, including Investor Day and R&D Day.
-
Royal Bank of Canada Mentioned together
A's shares received a moderate buy rating, indicating market coverage or analysis by B.
-
Munich Shared context
The company is involved in a strategic merger aimed at creating a vertically integrated radiopharmaceutical leader, with the partner based in Munich.
History
Events by the month they beganSeptember 2026
4 events- Telix agreed to acquire ITM Isotope Technologies Munich and is developing drugs that compete with Novartis.
- Merger aims to create a vertically integrated radiopharmaceutical leader.
- Telix Pharmaceuticals Limited announced that it is utilizing the Nasdaq exchange for its ADR listing.
- TELIX Pharmaceuticals is conducting Phase 3 trials and seeking alignment on the New Drug Application pathway with the FDA.
July 2026
1 eventJune 2026
6 events- Telix Pharmaceuticals Limited, headquartered in Melbourne, has international operations including in Europe and is listed on the Australian Securities Exchange.
- A company is developing Gozzellix, a next-generation PSMA-PET imaging agent, for prostate cancer treatment, benefiting from Trump-era tariffs and AI stocks.
- Strategic research partnership established in the US between TELIX PHARMACEUTICALS LIMITED and United Imaging Healthcare.
- Telix Pharmaceuticals Limited is headquartered in Melbourne, Australia, and an executive is attending a conference in Chicago.
- Telix Pharmaceuticals Limited is involved in activities related to Europe.
- Telix Pharmaceuticals acquired RLS and received FDA approval for a label expansion of its drug Illuccix.